CannabisNewsBreaks Archive - Page 92 of 420

WednesdayJun 16, 2021 9:57 am

CannabisNewsBreaks — Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Names New Auditor, Provides Filing Update

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has released an update regarding its annual filing statements for FY 2020, the period ended Dec. 31, 2020. The update also applies to other related documents, including the CEO and CFO certificates, an annual information form, and management’s discussion and analysis. RWB announced that it is now working with Macias Gini & O’Connell LLP (“MGO”) as the successor auditor to replace MNP LLP (“MNP”), the company RWB had previously contracted with. In addition, Red White & Bloom Brands noted that it will…

TuesdayJun 15, 2021 2:20 pm

CannabisNewsBreaks – Pure Extracts Technologies Corp.’s (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) BC Facility Ready to Meet Increasing Demand

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) is seeing interest from producers and brands looking for new opportunities and partnerships. In a corporate update focused on three points of interest in its growing business — cannabis, functional mushrooms and psilocybin — CEO Ben Nikolaevsky noted that the company’s Pemberton, British Columbia facility is fully operational and ready to meet the increasing demand for cannabis-based gummies, vapes and white-label products. According to a recent article, “The facility will be involved as the company ramps up production on its Pure Pulls and Pure Chews as they re-enter the market. In…

TuesdayJun 15, 2021 12:40 pm

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Looks to Focus Expertise on Psychedelic Drug Formulation as Manufacturing Programs Advance

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community. The audio press release discusses the company’s recent announcement regarding the status of its GMP mescaline synthesis program. “With both its North American GMP mescaline synthesis program and German-based psilocybin biotechnology production underway, the first stage of XPhyto's psychedelic medicine program is progressing on schedule. As the manufacturing programs advance,…

MondayJun 14, 2021 2:39 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Acreage Holdings Inc. (CSE: ACRG) (OTCQX: ACRHF) Complete Sale of Note

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, and Acreage Holdings (CSE: ACRG, ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) have announced additional information about the sale of a $28 million promissory notes that Acreage received as consideration for the previously announced sale of its Acreage Florida subsidiary to RWBYF. A multistate operator of cannabis ‎cultivation and retailing facilities in the United States, Acreage Holdings announced that it has completed the sale of the promissory notes. The notes, which are due from Red White and Bloom Brands, were sold to Viridescent Realty…

MondayJun 14, 2021 11:35 am

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Expands Hemp-Based Products with Pet CBD Tincture Targeting Anxiety, Joint Pain

Grapefruit USA (OTCQB: GPFT), a California-based hemp and cannabis company, today announced that it is expanding its hemp-based cannabidiol (“CBD”) product line with a new U.S. Department of Agriculture (“USDA”) certified CBD pet tincture. The product targets two of the most common dog and cat ailments — anxiety and joint pain. “We understand that pet owners are now demanding organic, plant-based, natural remedies to keep their furry family members calm and in good health, and avoid the potential negative side effects of generic, synthetic pet medications,” said Bradley Yourist, co-founder and CEO of GPFT. “Grapefruit’s new Pet CBD Tincture meets…

FridayJun 11, 2021 1:00 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Enhancing Hourglass Brand Awareness on Heels of Successful E-Commerce Website Launch

Grapefruit USA (OTCQB: GPFT), a fully licensed premier manufacturer and distributor in the legal cannabis marketplace, can now offer both U.S. and international customers a convenient, one-stop shop to purchase its THC-free, hemp-derived CBD Hourglass-powered products. This is after the launch of its worldwide e-commerce website, www.HourglassOnlineStore.com, in May. A recent article quoted Grapefruit CEO Bradley Yourist as saying, “Grapefruit’s new, easy-to-navigate website will allow approved affiliates to sign up to market and sell our THC-free, hemp-derived CBD Hourglass products through their own Grapefruit-approved channels and platforms, which will allow Grapefruit to rapidly increase the availability of our CBD product…

FridayJun 11, 2021 12:11 pm

CannabisNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Looks to Increase Gross Margins Through Accretive Acquisition

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a consumer-driven cannabis company in medicinal and recreational marijuana market segments, recently completed the acquisition of a chain of five Oregon-based retail dispensaries, known as Homegrown, for a total consideration of about $9.75 million. “This transaction increases Chalice Brands’ retail store footprint from 7 to 12 locations in the state of Oregon,” reads an article discussing the move. The consideration paid is 0.9 times Homegrown’s first quarter 2021 annualized revenue. “The fact that Homegrown is profitable makes this a highly accretive acquisition for the company’s earnings per share. It is anticipated that consumers will…

FridayJun 11, 2021 11:50 am

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Committed to Development of Evidence-Based ECS-Modulating Cannabinoid Products

Green Hygienics Holdings (OTCQB: GRYN) and Cinvestav, the Center for Research and Advanced Studies of the National Polytechnic Institute of Mexico, have recently entered a scientific research agreement and are collaborating to develop cannabinoid-based products targeting endocannabinoid system (“ECS”) deficiencies in animals and humans. Green Hygienics intends to leverage the collaboration in addition to its newly launched company, TruLife Biotech LLC, to develop products necessary for ECS deficiencies. “To further support the initiative, Green Hygienics has published a White Paper through Nutritional Outlook, an MJH Life Sciences(TM) brand that provides intelligent, well-informed insights and industry updates critical to the manufacturers…

ThursdayJun 10, 2021 2:45 pm

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Eyes Exciting Month in Commencement of Production, Sales of CBD Gummies

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has developed and is in production of innovative, high potency CBD edible gummies for the Canadian market. “June is going to be a very exciting month for us as we commence sales of gummies through our distribution partner,” said Pure Extracts CEO Ben Nikolaevsky. “The edible gummie business is a material revenue producer for Pure Extracts. We plan to replicate the success…

ThursdayJun 10, 2021 1:03 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Subsidiary Publishes Data Report on Medical Cannabis Use for Pain Management

RYAH Group (CSE: RYAH) today announced that its wholly owned subsidiary, RYAH Medtech Inc., has published a data report on the use of medical cannabis among patients with pain conditions. According to the update, the report features insights into the use of cannabis to treat pain conditions by patients within the RYAH Data ecosystem and whether cannabis may be one of the alternative treatment solutions to reduce opioid use-related problems associated with existing treatment options. “The RYAH data report on cannabis use for pain management comes at a turning point as studies on alternatives to opioids in treatment and potential…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks